A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
Varun Monga(University of Iowa), Mohammed Milhem(University of Iowa), Brian A. Van Tine(Washington University in St. Louis), Keith M. Skubitz(University of Minnesota Medical Center), Mark Agulnik(Northwestern University), Angela C. Hirbe(Washington University in St. Louis), Sarah L. Mott(University of Iowa), Steven Attia(Mayo Clinic in Florida), Seth Maliske(University of Iowa), Mahesh Seetharam(Mayo Clinic in Arizona), Hilary Dietz(Washington University in St. Louis), John A. Charlson(Medical College of Wisconsin), Peter Oppelt(Washington University in St. Louis), Steven I. Robinson(Roswell Park Comprehensive Cancer Center), Madeline O’Connor(St. Jude Children's Research Hospital), Scott H. Okuno(Mayo Clinic)
Cited by 57
Related Papers
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
|Journal of Clinical Oncology|2018|473
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
|Journal of Surgical Oncology|2008|419
Redefined Nomenclature for Members of the Carcinoembryonic Antigen Family
|Experimental Cell Research|1999|408